Healthcare - Biotechnology - NASDAQ - US
$ 5.8
-3.65 %
$ 328 M
Market Cap
-6.82
P/E
Price Target
Average
224.71%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
19.30%
Net Income
Estimate
--6.48%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Design Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for DSGN of $18.8 , with forecasts ranging from a low of $7 to a high of $42 .
DSGN Lowest Price Target
Wall Street Target
7 USD
20.69%
DSGN Average Price Target
Wall Street Target
18.8 USD
224.71%
DSGN Highest Price Target
Wall Street Target
42 USD
624.14%
REVENUE FORECAST
Revenue Forecast Chart DSGN
EBIT FORECAST
EBIT Forecast Chart DSGN
NET INCOME FORECAST
Net Income Chart DSGN